药品注册申请号：078593
申请类型：ANDA (仿制药申请)
申请人：WOCKHARDT
申请人全名：WOCKHARDT LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) No No AP 2009/02/06 2009/02/06 Prescription
批准日期，申请提交历史，通知信，药品说明书，审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级；罕用药状态通知信、审评文件、说明书、包装标签备注
2009/02/06 ORIG-1（原始申请） Approval
与本品相关的专利信息（来自FDA橙皮书Orange Book）
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
无
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
无
与本品治疗等效的药品
活性成分:SUMATRIPTAN SUCCINATE 剂型/给药途径:INJECTABLE;SUBCUTANEOUS 规格:EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
020080 001 NDA IMITREX SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) Discontinued Yes No AP 1992/12/28 GLAXOSMITHKLINE
078593 001 ANDA SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) Prescription No No AP 2009/02/06 WOCKHARDT
079123 001 ANDA SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) Prescription No No AP 2009/02/06 WEST-WARD PHARMS INT
079242 001 ANDA SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) Prescription No No AP 2009/03/02 FRESENIUS KABI USA
077332 001 ANDA SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) Discontinued No No AP 2009/10/09 PAR PHARM
202758 001 ANDA SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) Prescription No Yes AP 2013/04/23 EUGIA PHARMA
200183 001 ANDA SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) Prescription No No AP 2013/09/16 HIKMA
213998 001 ANDA SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) Prescription No No AP 2021/07/13 SOMERSET
207101 001 ANDA SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) Discontinued No No AP 2023/01/19 BAXTER HLTHCARE CORP
更多信息
药品NDC数据与药品包装、标签说明书
参考引用1
参考引用2
©2006-2024 DrugFuture->U.S. FDA Drugs Database